![Claudine Bruck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Claudine Bruck
Directeur/Membre du Conseil chez
ANNOVIS BIO, INC.
Fortune : 35 864 $ au 31/08/2026
Profil
Claudine E.
Bruck was the founder of Prolifagen, Inc., founded in 2016, where the title held was Chief Executive Officer from 2016 to 2022.
Current jobs include Independent Director at Annovis Bio, Inc. since 2015, Director at Ophidion, Inc., Course Director at Institute For Translational Medicine & Therapeutics, and Chief Scientific Officer at SapVax LLC.
Former jobs include Independent Director at Navidea Biopharmaceuticals, Inc. from 2018 to 2021, Course Director at the University of Pennsylvania, Vice President & Head-Biology at Center of Excellence For External Drug Discovery from 2005 to 2008, Head-Cancer Vaccine Program at GlaxoSmithKline LLC, and Assistant Professor at Tufts University School of Medicine.
Education includes doctorates from Vrije Universiteit Brussel and Harvard Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ANNOVIS BIO INC 0,05% | 04/09/2026 | 20 851 ( 0,05% ) | 35 864 $ | 31/08/2026 |
Postes actifs de Claudine Bruck
| Sociétés | Poste | Début |
|---|---|---|
| ANNOVIS BIO, INC. | Directeur/Membre du Conseil | 01/01/2015 |
SapVax LLC
 SapVax LLC Pharmaceuticals: MajorHealth Technology Develops cancer vaccines based on a novel self-adjuvanting peptide platform technology for immuno-oncology applications | Directeur Technique/Scientifique/R&D | - |
Ophidion, Inc.
 Ophidion, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutics for cognitive impairment diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Claudine Bruck
| Sociétés | Poste | Fin |
|---|---|---|
| NAVIDEA BIOPHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 14/09/2021 |
Center of Excellence For External Drug Discovery | Corporate Officer/Principal | 01/01/2008 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | - |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formation de Claudine Bruck
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
36
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Navidea Biopharmaceuticals, Inc.
 Navidea Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and commercializes precision diagnostics and radiopharmaceutical agents | Health Technology |
Annovis Bio, Inc.
 Annovis Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vrije Universiteit Brussel
 Vrije Universiteit Brussel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Tufts University School of Medicine
Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SapVax LLC
SapVax LLC Pharmaceuticals: MajorHealth Technology Develops cancer vaccines based on a novel self-adjuvanting peptide platform technology for immuno-oncology applications | Health Technology |
Prolifagen LLC
 Prolifagen LLC BiotechnologyHealth Technology Develops ribonucleic acid therapeutics intended for cardiac tissue regeneration | Health Technology |
Center of Excellence For External Drug Discovery | |
Ophidion, Inc.
Ophidion, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutics for cognitive impairment diseases | Health Technology |
